Your Sorted CME/CE Activities

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma
Certified CME/CNE Webcasts
Treatment paradigms for multiple myeloma have changed substantially over the last years with many advances in novel therapeutic approaches.

Presented by Dr. Joseph Mikhael of the Translational Genomics Research Institute, City of Hope Cancer Center, and Chief Medical Officer of the International Myeloma Foundation, this certified-CME/CNE 1-hour live webcast will cover recent updates in the standard of care and review the latest approved products and new research for the management of multiple myeloma. At the conclusion of the webcast a live question and answer session will be conducted. The activity will be available for 1 CME/CNE credit hour based on confirmed participation and the completion of an evaluation and posttest.
Please register for the activity and date of interest by clicking the corresponding button on the right.


Joseph Mikhael, MD, MEd, FRCPC, FACP Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery,
Translational Genomics Research Institute (TGen),
City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program,
HonorHealth Research Institute
Adjunct Professor, College of Health Solutions,
Arizona State University
 

20
Supported by an independent educational grant from GlaxoSmithKline and Karyopharm Therapeutics
September 24, 2020
Mini Module
6808
MultipleMyeloma_WebBanner(1150).gif
Hem-Onc